BioLineRx (BLRX) Return on Sales [ROS] (2018 - 2026)
BioLineRx's Return on Sales [ROS] was -1215.31% in the quarter ended Jun 30, 2026, down 457.74 percentage points from -757.57% a year earlier.
Powered by 
Analysis
BioLineRx (BLRX) Return on Sales [ROS] (2018 - 2026) Analysis & Trends
On a trailing twelve-month basis, BioLineRx's Return on Sales [ROS] was -998.36% through Jun 30, 2026, down 914.27 percentage points year-over-year; for the year ended Dec 31, 2025, it was -871.78%, down 801.26 percentage points from the prior year.
- In earlier years, Return on Sales [ROS] was -70.52% in the year ended Dec 31, 2024 (+964.77 pp) and -1035.29% in the year ended Dec 31, 2023.
- Quarterly Return on Sales [ROS] has moved between -1745.36% (the quarter ended Dec 31, 2025) and -37.67% (the quarter ended Dec 31, 2024) over five years.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 28.37% |
| 10 | BioLineRx | 9.01 Mn | -64.66 Mn | 235,000.00 | -1,215.31% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1,215.31% |
| Dec 31, 2025 | -1,745.36% |
| Sep 30, 2025 | -516.86% |
| Jun 30, 2025 | -757.57% |
| Mar 31, 2025 | -937.65% |
| Dec 31, 2024 | -37.67% |
| Sep 30, 2024 | -108.98% |
| Jun 30, 2024 | -107.05% |
| Mar 31, 2024 | -70.34% |
| Sep 30, 2021 | -1,883.94% |
| Mar 31, 2021 | -1,390.05% |
| Sep 30, 2020 | -730.97% |
| Mar 31, 2020 | -1,493.45% |
| Sep 30, 2019 | -813.10% |
| Mar 31, 2019 | -928.12% |
| Sep 30, 2018 | -56,472.73% |
API Access
BioLineRx Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=BLRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "BLRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=BLRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();